Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.03
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Rayont Inc., through its subsidiary, THF Holdings Pty Ltd., operates as a cancer treatment and medical device company. The company was formerly known as Velt International Group Inc. Rayont Inc. was founded in 2011 and is based in Southport, Australia.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'expensive' on P/E.
Data is available to registered users only
Buy
Sell